![Maria-Luisa Maccecchini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria-Luisa Maccecchini
Directeur Général chez
ANNOVIS BIO, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Maria-Luisa Maccecchini is the founder of Annovis Bio, Inc., founded in 2008, holding the titles of President, Chief Executive Officer, CFO & Director.
Dr. Maccecchini is the founder of Annovis, Inc., founded in 1992, holding the title of Chief Executive Officer from 1992 to 2001.
Dr. Maccecchini is also the founder of Message Pharmaceuticals, Inc...
Dr. Maccecchini currently serves as an Independent Director at Treventis Corp.
Dr. Maccecchini currently serves as an Independent Director at Lantern Pharma, Inc. since 2022.
Former positions include Director at Protez Pharmaceuticals, Inc., Director at Translational Development Acquisition Corp., Head-Molecular Biology at Mallinckrodt, Inc.(Old), Member at Robin Hood Ventures, General Manager at Bachem Bioscience, Inc. from 1987 to 1991, Head-Molecular Biology at Mallinckrodt LLC, and Member at Mid-Atlantic Angel Group from 2005 to 2013.
Education includes a doctorate from The Rockefeller University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANNOVIS BIO INC 3,08% | 28/04/2026 | 1 068 459 ( 3,08% ) | 2 M $ | 31/05/2026 |
LANTERN PHARMA, INC. -.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Maria-Luisa Maccecchini
| Sociétés | Poste | Début |
|---|---|---|
| ANNOVIS BIO, INC. | Directeur Général | 01/05/2008 |
| LANTERN PHARMA INC. | Directeur/Membre du Conseil | 08/06/2022 |
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Maria-Luisa Maccecchini
| Sociétés | Poste | Fin |
|---|---|---|
Robin Hood Ventures
 Robin Hood Ventures Investment ManagersFinance RHV invests in companies located in the United States. The firm targets companies operating in the fields of consumer products, information tech, biotechnology, hardtechnology, healthcare and medical devices. It provides financing for seed and early stage capital requirements with an investment size ranging between USD 0.5 - 3 million. It also makes follow on investments and takes a board seat. | Private Equity Investor | 30/11/2008 |
Annovis, Inc.
 Annovis, Inc. Chemicals: SpecialtyProcess Industries Develops, manufactures, and markets a wide vairety of nucleic acid based products and services for the life sciences sector | Directeur Général | 01/01/2001 |
Bachem Bioscience, Inc. | Corporate Officer/Principal | 01/01/1991 |
Message Pharmaceuticals, Inc.
 Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Directeur Général | - |
| TRANSLATIONAL DEVELOPMENT ACQUISITION CORP. | Directeur/Membre du Conseil | - |
Formation de Maria-Luisa Maccecchini
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Mallinckrodt, Inc.(Old)
 Mallinckrodt, Inc.(Old) Medical SpecialtiesHealth Technology Develops, manufactures and markets medical products | Health Technology |
Annovis Bio, Inc.
 Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
Annovis, Inc.
Annovis, Inc. Chemicals: SpecialtyProcess Industries Develops, manufactures, and markets a wide vairety of nucleic acid based products and services for the life sciences sector | Process Industries |
Protez Pharmaceuticals, Inc.
 Protez Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Robin Hood Ventures
Robin Hood Ventures Investment ManagersFinance RHV invests in companies located in the United States. The firm targets companies operating in the fields of consumer products, information tech, biotechnology, hardtechnology, healthcare and medical devices. It provides financing for seed and early stage capital requirements with an investment size ranging between USD 0.5 - 3 million. It also makes follow on investments and takes a board seat. | Finance |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mid-Atlantic Angel Group
 Mid-Atlantic Angel Group Investment ManagersFinance Alternative investment manager | Finance |
Message Pharmaceuticals, Inc.
Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Bachem Bioscience, Inc. | |
Treventis Corp.
Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Health Technology |
Mallinckrodt LLC
 Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Lantern Pharma, Inc.
 Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
Translational Development Acquisition Corp.
 Translational Development Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Choisissez Zonebourse 
